A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.
Clinical trial NCT01206764 · COMPLETED
Trial details
- NCT number
- NCT01206764
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-11
- Primary completion
- 2017-06-06
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.